Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M‑positive non‑small cell lung cancer
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2018
|
| In: |
Journal of cancer research and clinical oncology
Year: 2018, Volume: 144, Issue: 12, Pages: 2457-2463 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-018-2754-x |
| Online Access: | Resolving-System, Volltext: https://doi.org/10.1007/s00432-018-2754-x |
| Author Notes: | Jan A. Stratmann · Sebastian Michels· Sofia Hornetz · Daniel C. Christoph, Sandra Sackman, Werner Spengle, Helge Bischof, Monica Schäfer, Jürgen Alt, Annette Müller, Eckart Laack, Martin Kimmich, Frank Griesinger, Martin Sebastian |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-018-2754-x |